Horse Melanoma in Grey Horses: Welfare and Management

Grey horses have an exceptionally high prevalence of melanoma, with up to 80 percent developing tumours by age 15, making this one of the most significant welfare concerns for this coat colour.

Key Facts

The greying gene (STX17) is linked to accumulation of pigment cells that can undergo melanomatous transformation
Melanomas in grey horses typically appear under the tail, around the anus, on the head, and in the throat area
Unlike human melanomas, equine melanomas are often slow-growing but can become locally invasive or metastasise
Tumours near the anus can obstruct defecation; throat area tumours can compress the airway
Cimetidine (a histamine antagonist) was historically used but evidence for efficacy is weak
Electrochemotherapy, surgical excision, and newer immunotherapy approaches are being evaluated

Welfare Considerations

Melanomas cause welfare problems through local pressure effects, ulceration, secondary infection, and interference with normal bodily functions. A horse with large perianal tumours may strain to defecate, suffer from faecal impaction, or experience chronic discomfort. Throat tumours can cause dysphagia and respiratory difficulty. The progressive nature of the condition means welfare monitoring must be ongoing throughout the horse's life. Early identification and monitoring by a veterinarian allows treatment before tumours reach problematic sizes, and palliative care focuses on keeping the horse comfortable and functional for as long as possible.

What You Can Do

Schedule annual full-body examination for grey horses with specific attention to common melanoma sites from age 5
Document tumour sizes with measurements or photographs at each vet visit to track growth rate
Consult an equine oncologist if tumours are near functional structures such as the anus or throatlatch area
Support equine welfare research into melanoma treatment through organisations such as World Horse Welfare